Sign in with Google. Opens in new tab
bullish

MIRA: IND Application Submitted to FDA

396 Views19 Dec 2024 16:05
Issuer-paid
MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report
What is covered in the Full Insight:
  • Introduction to MIRA Pharmaceuticals
  • IND Application and Phase 1 Trials
  • Preclinical Study Results for Ketamir-2
  • Comparative Analysis with Existing Treatments
  • Investment Outlook and Recommendations
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 6-minute read)
Related Insights
More »
    Loading
Trending Collections
More »
    Loading
Trending Insights
More »
    Loading
Top Unpaywalled Insights
More »
    Loading
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x